ES2149850T3 - Utilizacion de la selegilina en medicina veterinaria. - Google Patents

Utilizacion de la selegilina en medicina veterinaria.

Info

Publication number
ES2149850T3
ES2149850T3 ES94400949T ES94400949T ES2149850T3 ES 2149850 T3 ES2149850 T3 ES 2149850T3 ES 94400949 T ES94400949 T ES 94400949T ES 94400949 T ES94400949 T ES 94400949T ES 2149850 T3 ES2149850 T3 ES 2149850T3
Authority
ES
Spain
Prior art keywords
selegiline
veterinary medicine
cats
dogs
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94400949T
Other languages
English (en)
Inventor
Marie Sophie Filhol
Thierry Pobel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26230300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2149850(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9305305A external-priority patent/FR2704756B1/fr
Priority claimed from FR9315495A external-priority patent/FR2713930B3/fr
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Application granted granted Critical
Publication of ES2149850T3 publication Critical patent/ES2149850T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE LA SELEGILINA PARA PREPARAR COMPOSICIONES FARMACEUTICAS UTILES PARA TRATAR TRASTORNOS DEL COMPORTAMIENTO CON ALTERACION DEL HUMOR EN LOS PERROS Y LOS GATOS.
ES94400949T 1993-05-04 1994-05-02 Utilizacion de la selegilina en medicina veterinaria. Expired - Lifetime ES2149850T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9305305A FR2704756B1 (fr) 1993-05-04 1993-05-04 Utilisation de la sélégiline en médecine vétérinaire.
FR9315495A FR2713930B3 (fr) 1993-12-22 1993-12-22 Utilisation de la Sélégiline en médecine vétérinaire.

Publications (1)

Publication Number Publication Date
ES2149850T3 true ES2149850T3 (es) 2000-11-16

Family

ID=26230300

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94400949T Expired - Lifetime ES2149850T3 (es) 1993-05-04 1994-05-02 Utilizacion de la selegilina en medicina veterinaria.

Country Status (9)

Country Link
US (1) US5547995B1 (es)
EP (1) EP0623344B1 (es)
AT (1) ATE194911T1 (es)
CA (1) CA2122780C (es)
DE (1) DE69425345T2 (es)
DK (1) DK0623344T3 (es)
ES (1) ES2149850T3 (es)
GR (1) GR3034661T3 (es)
PT (1) PT623344E (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2290381A1 (en) 1997-05-21 1998-11-26 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US6262111B1 (en) 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
CZ200434A3 (cs) * 2001-07-20 2005-02-16 Pfizer Products Inc. Léčivo pro léčení abnormálního úzkosného chování u domácích zvířat a způsob screeningu zkoušené sloučeniny za účelem stanovení anxiolytické účinnosti u psů
EP1662895A1 (en) * 2003-09-10 2006-06-07 Hill's Pet Nutrition Oleamide-containing composition for animal consumption
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
JPH06506204A (ja) * 1991-04-04 1994-07-14 ザ・ユニバーシティ・オブ・トロント・イノベイションズ・ファウンデイション 神経細胞機能を維持し、喪失を防止し、または回復させるためのデプレニールの使用

Also Published As

Publication number Publication date
CA2122780A1 (fr) 1994-11-05
CA2122780C (fr) 2004-01-20
EP0623344A1 (fr) 1994-11-09
DE69425345T2 (de) 2001-03-01
PT623344E (pt) 2000-12-29
ATE194911T1 (de) 2000-08-15
GR3034661T3 (en) 2001-01-31
DE69425345D1 (de) 2000-08-31
US5547995B1 (en) 1998-01-27
DK0623344T3 (da) 2000-12-18
US5547995A (en) 1996-08-20
EP0623344B1 (fr) 2000-07-26

Similar Documents

Publication Publication Date Title
ES2099977T3 (es) Composiciones de liberacion prolongada para tratar enfermedades periodontales.
DE69324859D1 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
ES2067696T3 (es) Composiciones de liberacion sostenida para tratar la enfermedad periodontal.
CY1105221T1 (el) Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις
FI941245A (fi) Menetelmä 2'-deoksiguanosiinin asyylijohdannaisten valmistamiseksi
ES2082834T3 (es) Composiciones con liberacion prolongada para tratar enfermedades periodontales.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR1100384A (pt) Composto e formulação farmacêutica
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
BR0009524A (pt) Uso de um composto, e, composição farmacêutica ou veterinaria
MX9205358A (es) Compuestos para tratar enfermedades relacionadas con leucotrieno.
US5547995B1 (en) Use of selegiline in veterinary medicine
ATE74267T1 (de) Tiermedizinische behandlung.
BR9200218A (pt) Aparelho e processo para o processamento de fibra animal,particurlamente la crua
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
BR0204547A (pt) Pirazóis de 5-heteroátomo-substituìdo
ES2055030T3 (es) Antibioticos de 1-carbacefalosporina.
DE69203071D1 (de) Verfahren zur erhoehung der therapeutischen wirksamkeit fettloeslicher fungizideaus der familie der imidazole sowie mittel zur durchfuehrung dieses verfahren.
DE69202142D1 (de) Verfahren und Vorrichtung zur Herstellung von Zwischenprodukten zur Herstellung von Tierfutter.
DE69112718D1 (de) Verfahren und Zusammensetzung zur Behandlung von tierischen Exkrementen.
FR2682046B1 (fr) Casier homogeneisateur pour la conservation de doses d'insemination artificielle d'animaux tels que des truies.
FR2708202B1 (fr) Implant biocompatible pour l'expression chez l'homme ou chez l'animal de substances déterminées.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
GB0003234D0 (en) Method of treatment
MY114109A (en) The use of bioassimilable boron compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 623344

Country of ref document: ES